COUNTERPOINT: Despite staging inaccuracies, patients with non-small cell lung cancer are best served by having integrated positron emission tomography/computed tomography before therapy

Journal of Thoracic and Cardiovascular Surgery

Volumn 137, Issue 1, 2009, Pages 20-22

  Cerfolio, Robert J ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

CANCER STAGING; CANCER THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; EDITORIAL; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPHADENECTOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORACOTOMY;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58249089781     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.08.048     Document Type: Editorial

References (11)

1. Stiles B.M., Lee P.C., Servais E.C., Port J.L., Paul S., Meherally D., et al. Clinical stage IA lung cancer by CT and PET scan: the persistent problem of understaging. J Thorac Cardiovasc Surg 137 (2009) 13-19
2. Cerfolio R.J., Ojha B., Bryant A.S., Raghuveer V., Mountz J.M., and Bartolucci A.A. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 78 (2004) 1017-1023
3. Shim S.S., Lee K.S., Kim B.T., Chung M.J., Lee E.J., Han J., et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 236 (2005) 1011-1019
4. Lardinois D., Weder W., Hany T.F., Kamel E.M., Korom S., Seifert B., et al. Staging of non-small cell lung cancer with integrated positron emission tomography and computed tomography. N Engl J Med 348 (2003) 2500-2507
5. Cerfolio R.J., Bryant A.S., Ojha B., and Eloubeidi M. Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. Ann Thorac Surg 80 (2005) 1207-1213
6. Cerfolio R.J., Bryant A.S., and Ojha B. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. J Thorac Cardiovasc Surg 131 (2006) 1229-1235 Erratum in: J Thorac Cardiovasc Surg. 2006;132:565-7
7. Cerfolio R.J., and Bryant A.S. Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study. J Thorac Cardiovasc Surg 135 (2008) 261-268
8. Erasmus J.J., Macaplinac H.A., and Swisher S.G. Positron emission tomography imaging in non small-cell lung cancer. Cancer 110 (2007) 2155-2168
9. Craanen M.E., Comens E.F., Paul M.A., and Smit E.F. Endoscopic ultrasound guided fine-needle aspiration and 18FDG-positron emission tomography in the evaluation of patients with non-small cell lung cancer. Interact Cardiovasc Thorac Surg 6 (2007) 433-436
10. Yasufuku K., Nakajima T., Motoori K., Sekine Y., Shibuya K., Hiroshima K., et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest 130 (2006) 710-718
11. Bryant A.S., Cerfolio R.J., Klemm K.M., and Ojha B. Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer. Ann Thorac Surg 82 (2006) 417-422